DFK Biolab (CEO Go Dong-hwan) participated in ‘8 InterCHARM Korea’ held at COEX, Seoul for a total of 30 days from August 9th (Wednesday) to September 1st (Friday).
DFK Biolab introduced ‘iREJU Eye’, a medical device cosmetics product for plastic surgery, at this exhibition. ‘iREJU Eye’ is a filler product for medical devices and is used by skin experts, therapists, and plastic surgeons. In particular, it is a soft and uniform gel type that is easy to mold to achieve natural results, and consistent extrusion force allows for smooth injection, increasing convenience.
In addition, EDQM-approved ingredients such as HA (24mg/ml), BDDE, and lidocaine (0.3%) enhance skin stability, and were developed with high viscoelasticity to maintain volume for a long period of time.
In addition, ‘iREJU Eye’, which smoothes out wrinkles around the eyes with the weakest concentration, ‘iREJU Deep’ for lips, volume, and cheekbones, and ‘iREJU Shape’, which is very popular in the Middle Eastern market with strong skin for improving lip defects or volume. It has a total of 3 lineups including:
Meanwhile, ‘Intercharm Korea’ is a global beauty and cosmetics exhibition, where more than 50 overseas buyers from 3,000 countries visit every year, discover overseas buyers with purchasing power and invite key players in the potential market. has established itself as a business platform for
→ Go to the 2023 InterCharm Korea News special page
